How Hormone Therapy is used with other cancer treatments
Hormone therapy often forms part of a comprehensive treatment plan, working alongside surgery, radiation, chemotherapy, and newer targeted or immune-based therapies.
Hormone therapy with surgery is common in breast and prostate cancers. Treatment usually continues for years after tumor removal to reduce recurrence risk by targeting microscopic hormone-dependent cells.
Hormone therapy with radiation creates synergistic effects in prostate cancer. Men receiving radiation for intermediate or high-risk disease take hormone therapy before, during, and after radiation for better control.
Hormone therapy with chemotherapy may be used sequentially. Many breast cancer patients receive chemotherapy first to quickly reduce tumor burden, then continue long-term hormone therapy for sustained disease control.
Hormone therapy with targeted therapy is used in select patients, such as HER2-positive or BRCA-mutated cancers, where blocking hormone signals and specific molecular pathways together improves outcomes.
Hormone therapy with immunotherapy is being explored in advanced disease. Carefully selected combinations may enhance immune recognition while maintaining hormonal control of tumor growth.